Compounds > tobramycin
Page last updated: 2024-08-23

tobramycin and Adverse Drug Event

tobramycin has been researched along with Adverse Drug Event in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Campino, A; Garcia, M; Rueda, M; Santesteban, E; Valls-I-Soler, A1
de Jonge, E; Mol, M; Schultz, MJ; van Kan, HJ1

Other Studies

5 other study(ies) available for tobramycin and Adverse Drug Event

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
[Intravenous drug preparation errors in a Neonatal Intensive Care Unit. A potential source of adverse events].
    Anales de pediatria (Barcelona, Spain : 2003), 2013, Volume: 79, Issue:1

    Topics: Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Humans; Infant, Newborn; Injections, Intravenous; Intensive Care Units, Neonatal; Medication Errors; Prospective Studies; Tobramycin; Vancomycin

2013
Systemic tobramycin concentrations during selective decontamination of the digestive tract in intensive care unit patients on continuous venovenous hemofiltration.
    Intensive care medicine, 2008, Volume: 34, Issue:5

    Topics: Acute Kidney Injury; Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Tract; Hemofiltration; Humans; Intestinal Absorption; Male; Middle Aged; Prospective Studies; Tobramycin

2008